Velcade and multiple myeloma Patient Reports February 11, 2012

Velcade Side Effects Report #5080830-6
Velcade side effect was reported by a Physician from GERMANY on Aug 05, 2005. Female patient, 69 years of age, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: bundle branch block right, chest pain , haemoglobin decreased, malignant neoplasm progression, multiple myeloma , myocardial infarction, osteolysis, tachycardia. Velcade dosage: unknown. During the same period patient was treated with PANTOZOL, NOVALGIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4607676-4
Velcade side effect was reported by a Physician from on Mar 01, 2005. Female patient, 50 years of age, weighting 253.5 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood lactate dehydrogenase increased, cranial nerve palsies multiple, diplopia, headache , malignant neoplasm progression, multiple myeloma , proteinuria. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died.

Velcade Side Effects Report #5843039-1
Velcade side effect was reported by a Physician from SWITZERLAND on July 29, 2008. Female patient, 89 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , renal failure. Velcade dosage: 1.3 MG/M2 UNK UNK. During the same period patient was treated with DEXAMETHASONE. Patient died on 07/09/2007.

Velcade Side Effects Report #5387450-4
Velcade side effect was reported by a Physician from JAPAN on July 02, 2007. Female patient, 83 years of age, weighting 83.78 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: ascites, hyponatraemia, liver disorder, malignant neoplasm progression, multiple myeloma , nerve injury, neuropathy peripheral, platelet count decreased, pleural effusion. Velcade dosage: unknown. During the same period patient was treated with DECADRON, SULFAMETHOXAZOLE, DIFLUCAN, MUCOSTA, POLYMYXIN B SULPHATE, OMEPRAL, MAGNESIUM OXIDE. Patient was hospitalized and became disabled. Patient died on 05/27/2007.


Velcade Side Effects Report #5569873-3
Velcade side effect was reported by a Physician from UNITED STATES on Dec 06, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacteraemia, malignant neoplasm progression, multiple myeloma , neutropenia, sepsis , thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with REVLIMID. Patient died on 06/26/2007.

Velcade Side Effects Report #5214194-1
Velcade side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia, renal failure acute, respiratory failure. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID. Patient was hospitalized. Patient died on 11/18/2006.

Velcade Side Effects Report #5266999-9
Velcade side effect was reported by a Physician from UNITED STATES on Mar 01, 2007. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia. Velcade dosage: 1.90 MG,INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID, LASIX, MICRO, DURAGESIC, ZOFRAN, ZOMETA, PROCRIT. Patient was hospitalized. Patient died on 11/18/2006.

Velcade Side Effects Report #5169057-7
Velcade side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia, renal failure acute. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID. Patient was hospitalized. Patient died on 11/18/2006.

Velcade Side Effects Report #5324056-7
Velcade side effect was reported by a Physician from FRANCE on Apr 25, 2007. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.20 MG, INTRAVENOUS. Patient died.


Velcade Side Effects Report #5551274-5
Velcade side effect was reported by a Physician from JAPAN on Nov 26, 2007. Female patient, 80 years of age, weighting 74.96 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, haemoglobin decreased, malignant neoplasm progression, multiple myeloma , platelet count decreased. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOSAMAX, ALDACTONE, DIFLUCAN, TENORMIN, ASPIRIN, BAKTAR, PROTECADIN. Patient died on 10/24/2007.

Velcade Side Effects Report #5945816-5
Velcade side effect was reported by a Physician from JAPAN on Oct 22, 2008. Female patient, 80 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: multiple myeloma , neoplasm progression. Velcade dosage: unknown. Patient died on 10/22/2008.

Velcade Side Effects Report #5724964-9
Velcade side effect was reported by a Physician from ISRAEL on Apr 17, 2008. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma , pneumonia . Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with CADEX, OXYCOD, EPREX, DURAGESIC. Patient was hospitalized. Patient died on 02/29/2008.

Velcade Side Effects Report #5909044-1
Velcade side effect was reported by a Physician from NETHERLANDS on Sept 26, 2008. Male patient, 79 years of age, weighting 189.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypercalcaemia, malignant neoplasm progression, multiple myeloma . Velcade dosage: unknown. Patient was hospitalized. Patient died on 08/11/2008.

Velcade Side Effects Report #5927317-3
Velcade side effect was reported by a Consumer or non-health professional from NETHERLANDS on Oct 08, 2008. Male patient, 79 years of age, weighting 189.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypercalcaemia, malignant neoplasm progression, multiple myeloma . Velcade dosage: unknown. Patient was hospitalized. Patient died on 08/11/2008.


Velcade Side Effects Report #5584730-4
Velcade side effect was reported by a Physician from JAPAN on Dec 20, 2007. Female patient, 78 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, diarrhoea, malignant neoplasm progression, multiple myeloma , nausea , oedema, platelet count decreased, pulmonary oedema, pyrexia. Velcade dosage: 1.90 MG, 1.70 MG , 1.30 MG, 1.90 MG INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, HYDROCORTISONE, WARFARIN, ACECOL, ENDOXAN. Patient was hospitalized. Patient died on 05/12/2007.

Velcade Side Effects Report #6049546-3
Velcade side effect was reported by a Consumer or non-health professional from CANADA on Jan 15, 2009. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypercalcaemia, malignant neoplasm progression, multiple myeloma , neuropathy peripheral, oedema peripheral, somnolence. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, OXYCODONE, CELEXA, ZOPICLONE, MELPHALAN. Patient died on 03/22/2008.

Velcade Side Effects Report #4877339-9
Velcade side effect was reported by a Physician from CANADA on Dec 22, 2005. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, cerebral atrophy, cerebral ischaemia, confusional state, disease progression, herpes zoster disseminated, lumbar puncture abnormal, multiple myeloma , myopathy steroid. Velcade dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with PAMIDRONATE DI, BENADRYL, ACETAMINOPHEN, LORAZEPAM, EPREX, DOMPERIDONE, KYTRIL, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5580691-2
Velcade side effect was reported by a Physician from JAPAN on Dec 20, 2007. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatine increased, blood urea increased, disease progression, dyspnoea, metabolic acidosis, multiple myeloma , oedema, tumour lysis syndrome, weight increased. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, SELBEX, BAKTAR, ALLOPURINOL, METHYCOBAL. Patient died on 08/03/2007.

Velcade Side Effects Report #5788960-8
Velcade side effect was reported by a Physician from PHILIPPINES on June 14, 2008. Female patient, 77 years of age, weighting 198.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma . Velcade dosage: 1.3 MG. Patient died on 09/21/2007.


Velcade Side Effects Report #4806430-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 05, 2005. Male patient, 77 years of age, weighting 159.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium decreased, cardiac failure congestive, dialysis , disease progression, disease recurrence, limb injury, mood altered, multiple myeloma , nephritis. Velcade dosage: 1.30MG/M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, LOTENSIN, INSULIN, DURAGESIC, PROTONIX, MOBIC, VITAMIN C. Patient was hospitalized. Patient died on 08/26/2005.

Velcade Side Effects Report #5214702-0
Velcade side effect was reported by a Physician from GERMANY on Jan 11, 2007. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: multiple myeloma . Velcade dosage: 1.30 MG. Patient died on 11/12/2006.

Velcade Side Effects Report #5483857-5
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 04, 2007. Female patient, 76 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.79 MG. Patient was hospitalized. Patient died on 09/29/2007.

Velcade Side Effects Report #5741393-2
Velcade side effect was reported by a Physician from FRANCE on May 02, 2008. Male patient, 76 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood viscosity increased, confusional state, hypercalcaemia, malignant neoplasm progression, multiple myeloma , protein total increased. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, LASIX, ODRIK, VASTAC, DIANTALVIC, DIALGIREX, BONIVA. Patient was hospitalized. Patient died on 04/18/2008.

Velcade Side Effects Report #4764789-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2003. Female patient, 76 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, confusional state, delirium, hallucinations, mixed, herpes zoster, malignant neoplasm progression, multiple myeloma , speech disorder. Velcade dosage: 2MG BIW, IV BOLUS. During the same period patient was treated with EFFEXOR, SPIRONOLACTONE, SYNTHROID, METHADONE, NEURONTIN. Patient died on 10/01/2003.


Velcade Side Effects Report #4791642-2
Velcade side effect was reported by a Physician from GERMANY on Sept 20, 2005. Female patient, 76 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, dehydration, disease progression, multiple myeloma . Velcade dosage: 1.50 MG, INTRAVENOUS. During the same period patient was treated with NOVALGIN, TEMGESIC. Patient was hospitalized. Patient died on 09/14/2005.

Velcade Side Effects Report #4944209-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 21, 2006. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure orthostatic decreased, disease progression, dizziness , haematocrit decreased, haematotoxicity, haemoglobin decreased, heart rate increased, multiple myeloma , thrombocytopenia. Velcade dosage: 2.80 MG, INTRAVENOUS. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #4976247-2
Velcade side effect was reported by a Physician from UNITED KINGDOM on Mar 31, 2006. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, multiple myeloma , neoplasm recurrence, platelet count decreased. Velcade dosage: unknown. During the same period patient was treated with OMEPRAZOLE, LACTULOSE, SANDOCAL, CLODRONATE DI. Patient died on 02/22/2006.

Velcade Side Effects Report #5591256-0
Velcade side effect was reported by a Physician from UNITED STATES on Jan 02, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma , pneumonia . Velcade dosage: unknown. During the same period patient was treated with REVLIMID, ZOMETA. Patient died on 06/02/2007.

Velcade Side Effects Report #5656259-6
Velcade side effect was reported by a Physician from UNITED KINGDOM on Feb 21, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.40 MG; 1.30 MG. Patient died on 01/31/2008.


Velcade Side Effects Report #5885683-1
Velcade side effect was reported by a Physician from JAPAN on Sept 03, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma . Velcade dosage: unknown. Patient died on 08/15/2008.

Velcade Side Effects Report #6123948-9
Velcade side effect was reported by a Physician from JAPAN on Mar 06, 2009. Female patient, 75 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, amyloidosis, depressed level of consciousness, disease progression, haematotoxicity, joint contracture, movement disorder , multiple myeloma , nerve compression. Velcade dosage: 1.8 MG, UNK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LANSOPRAZOLE, FLUCONAZOLE. Patient was hospitalized and became disabled. Patient died on 11/05/2008.

Velcade Side Effects Report #4958274-4
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Mar 09, 2006. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac enzymes increased, diarrhoea, haematemesis, hypothermia , malignant neoplasm progression, multiple myeloma , neutropenia, rectal haemorrhage. Velcade dosage: 210 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, ALLOPURINOL, AMLODIPINE, LOPERAMIDE. Patient died.

Velcade Side Effects Report #5330084-8
Velcade side effect was reported by a Consumer or non-health professional from FRANCE on May 02, 2007. Male patient, 74 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute leukaemia, chromosome analysis abnormal, condition aggravated, multiple myeloma , myelocytosis, neurotoxicity. Velcade dosage: 9.60 MG, INTRAVENOUS. During the same period patient was treated with ALKERAN, CYCLOPHOSPHAMIDE, THALIDOMIDE. Patient recovered.

Velcade Side Effects Report #5341867-2
Velcade side effect was reported by a Consumer or non-health professional from FRANCE on May 16, 2007. Male patient, 74 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, condition aggravated, multiple myeloma , myeloid leukaemia, neurotoxicity. Velcade dosage: 9.60 MG, UNK, INTRAVENOUS. During the same period patient was treated with ALKERAN, CYCLOPHOSPHAMIDE, THALIDOMIDE. Patient recovered.


Velcade Side Effects Report #5054141-9
Velcade side effect was reported by a Physician from ITALY on June 26, 2006. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to central nervous system, metastases to skin, multiple myeloma . Velcade dosage: 1.30 MG/M2. Patient died.

Velcade Side Effects Report #5115304-7
Velcade side effect was reported by a Physician from NETHERLANDS on Sept 11, 2006. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomyopathy , fatigue, heart rate increased, infection , malignant neoplasm progression, mitral valve incompetence, multiple myeloma , ventricular hypokinesia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died.

Velcade Side Effects Report #5129788-1
Velcade side effect was reported by a Physician from NETHERLANDS on Oct 04, 2006. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomyopathy , fatigue, infection , malignant neoplasm progression, mitral valve incompetence, multiple myeloma . Velcade dosage: 1.30 MG/M2 INTRAVENOUS. Patient died.

Velcade Side Effects Report #5723041-0
Velcade side effect was reported by a Physician from SWITZERLAND on Apr 22, 2008. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, haemolysis, multiple myeloma . Velcade dosage: unknown. Patient died.

Velcade Side Effects Report #5746167-4
Velcade side effect was reported by a Physician from SWITZERLAND on May 06, 2008. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemolysis, haemolytic anaemia, infection , malignant neoplasm progression, multiple myeloma . Velcade dosage: 2 MG, INTRAVENOUS, 1.5 MG, INTRAVENOUS. Patient died on 04/09/2008.


Velcade Side Effects Report #6128774-2
Velcade side effect was reported by a Physician from JAPAN on Mar 11, 2009. Male patient, 74 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: coma hepatic, hyperammonaemia, hyperventilation, malignant neoplasm progression, metabolic acidosis, multiple myeloma , no therapeutic response, psychiatric symptom, respiratory failure. Velcade dosage: 2.1 MG INTRAVENOUS. During the same period patient was treated with LANSOPRAZOLE, METHYCOBAL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ITRACONAZOLE, FENTANYL. Patient died on 02/18/2009.

Velcade Side Effects Report #5268364-7
Velcade side effect was reported by a Physician from JAPAN on Mar 02, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, malignant neoplasm progression, multiple myeloma , oliguria, renal disorder, renal failure, respiratory failure. Velcade dosage: 2.30 MG, IV DRIP. Patient died on 12/08/2006.

Velcade Side Effects Report #5292555-2
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 23, 2007. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute myocardial infarction, condition aggravated, hypertension, multiple myeloma , thrombocytopenia. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with GATIFLOXACIN, PAMIDRONATE DI, MEFENAMIC ACID. Patient died on 01/29/2007.

Velcade Side Effects Report #5811426-3
Velcade side effect was reported by a Physician from HUNGARY on July 07, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, multiple myeloma , pneumonia , sepsis , thrombocytopenia. Velcade dosage: 2.3 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #4617698-5
Velcade side effect was reported by a Physician from on Mar 11, 2005. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, depression , disease progression, multiple myeloma , pain , pneumonia , polyneuropathy. Velcade dosage: unknown. Patient died on 01/01/2005.

Velcade Side Effects Report #5312926-5
Velcade side effect was reported by a Health Professional from UNITED STATES on Apr 16, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, asthenia, disease progression, fall , multiple myeloma . Velcade dosage: 2.60 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5103999-3
Velcade side effect was reported by a Physician from GERMANY on Aug 31, 2006. Male patient, 72 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 05/27/2006.

Velcade Side Effects Report #5907654-9
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Sept 17, 2008. Male patient, 72 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, dyspnoea, multiple myeloma , myocardial infarction, neuropathy peripheral, pleural effusion, thrombocytopenia. Velcade dosage: 2.2 MG; 1.6 MG. Patient died on 07/25/2008.

Velcade Side Effects Report #6050693-0
Velcade side effect was reported by a Physician from JAPAN on Jan 09, 2009. Male patient, 71 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: unknown. Patient died on 10/01/2008.

Velcade Side Effects Report #4875492-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Dec 20, 2005. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma . Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, ZOMETA, ZOFRAN, DECADRON. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5215331-5
Velcade side effect was reported by a Physician from JAPAN on Jan 05, 2007. Male patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood calcium decreased, gastrointestinal haemorrhage, haemorrhagic diathesis, hypotension, mouth haemorrhage, multiple myeloma , pancytopenia, purpura. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, NEUPOGEN. Patient died on 12/26/2006.

Velcade Side Effects Report #5526144-9
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Aug 18, 2007. Male patient, 70 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bone erosion, compression fracture, hypertension, multiple myeloma , pyrexia. Velcade dosage: 4.00 MG. Patient was hospitalized. Patient died on 12/16/2006.

Velcade Side Effects Report #5601206-6
Velcade side effect was reported by a Physician from UNITED KINGDOM on Jan 09, 2008. Male patient, 70 years of age, weighting 179.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: colitis, multiple myeloma . Velcade dosage: unknown. During the same period patient was treated with ADRIAMYCIN, DEXAMETHASONE, GABAPENTIN, ZOMETA. Patient died on 11/11/2007.

Velcade Side Effects Report #5625233-8
Velcade side effect was reported by a Physician from JAPAN on Jan 30, 2008. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 01/10/2008.

Velcade Side Effects Report #5015873-1
Velcade side effect was reported by a Physician from CANADA on May 18, 2006. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient died on 12/03/2005.

Velcade Side Effects Report #5023337-4
Velcade side effect was reported by a Physician from CANADA on May 26, 2006. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, fatigue, malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with EPREX, HYDROCHLOROTHIAZIDE, VITAMIN D, VASOFED, ASCORBIC ACID, PAMIDRONATE DI. Patient was hospitalized. Patient died on 12/03/2005.

Velcade Side Effects Report #5165720-2
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Nov 16, 2006. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, infection , malignant neoplasm progression, multiple myeloma , thrombocytopenia. Velcade dosage: unknown. Patient was hospitalized. Patient died on 09/14/2006.

Velcade Side Effects Report #5570225-0
Velcade side effect was reported by a Physician from JAPAN on Dec 04, 2007. Female patient, 69 years of age, weighting 81.57 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood urea increased, c-reactive protein increased, disease progression, hypertension, malaise, multiple myeloma . Velcade dosage: 1.10 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, JUVELA, TAGAMET, PRAVASTATIN, ADONA, LENDORM, DIFLUCAN, BAKTAR. Patient died on 11/16/2007.

Velcade Side Effects Report #5704586-6
Velcade side effect was reported by a Physician from UNITED STATES on Mar 31, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: unknown. Patient died on 08/30/2007.

Velcade Side Effects Report #5954886-X
Velcade side effect was reported by a Physician from SPAIN on Nov 05, 2008. Female patient, 69 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , subdural haemorrhage, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died on 10/01/2008.


Velcade Side Effects Report #5959610-2
Velcade side effect was reported by a Physician from SPAIN on Nov 07, 2008. Female patient, 69 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, head injury, multiple myeloma , subdural haemorrhage, thrombocytopenia. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died on 10/01/2008.

Velcade Side Effects Report #4677011-4
Velcade side effect was reported by a Physician from on May 13, 2005. Male patient, 69 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacterial infection , bronchopulmonary aspergillosis, diarrhoea, disease progression, hyponatraemia, multiple myeloma , performance status decreased, sputum culture positive, staphylococcal infection . Velcade dosage: 2.46 MG, BIW, IV BOLUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5549729-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 27, 2007. Female patient, 68 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , transplant failure. Velcade dosage: unknown. During the same period patient was treated with REVLIMID, DECADRON. Patient died on 12/15/2006.

Velcade Side Effects Report #5633206-4
Velcade side effect was reported by a Health Professional from AUSTRALIA on Feb 04, 2008. Female patient, 68 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: multiple myeloma , procedural complication. Velcade dosage: 2.20 MG. During the same period patient was treated with DEXAMETHASONE, ZOLEDRONIC ACID. Patient recovered.

Velcade Side Effects Report #6024402-5
Velcade side effect was reported by a Physician from JAPAN on Dec 15, 2008. Male patient, 68 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.3 MG/M2, INTRAVENOUS. Patient died on 11/01/2008.

Velcade Side Effects Report #4648849-4
Velcade side effect was reported by a Health Professional from on Apr 13, 2005. Female patient, 68 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, disease progression, fall , fatigue, loss of consciousness, multiple myeloma , tremor. Velcade dosage: 1.20 MG, IV BOLUS. During the same period patient was treated with DURAGESIC, PRANDIN NOVO NORDISK, PHOSLO, AVAPRO, NORVASC, CARDURA, LOPERAMIDE, QUININE SULPHATE. Patient died on 01/25/2005.

Velcade Side Effects Report #5483820-4
Velcade side effect was reported by a Physician from UNITED STATES on Oct 03, 2007. Male patient, 67 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchoscopy abnormal, culture positive, disease progression, infection in an immunocompromised host, multiple myeloma , parainfluenzae virus infection, pneumonia , respiratory failure, staphylococcal infection . Velcade dosage: 1.30 MG/M2. Patient was hospitalized. Patient died on 01/01/2007.

Velcade Side Effects Report #5764264-4
Velcade side effect was reported by a Physician from UNITED STATES on May 27, 2008. Female patient, 67 years of age, weighting 153.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bone pain, cardiomegaly, hypercalcaemia, lethargy, malignant neoplasm progression, mental status changes, multiple myeloma . Velcade dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, DUONEB, MAGIC MOUTH WASH, FLUCONAZOLE, LIDOCAINE VISCOUS, ALLEGRA, ATIVAN, CARFATE. Patient was hospitalized. Patient died on 08/08/2007.

Velcade Side Effects Report #6134286-2
Velcade side effect was reported by a Pharmacist from UNITED KINGDOM on Mar 09, 2009. Female patient, 67 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , spinal cord compression. Velcade dosage: 2.2 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 02/20/2009.

Velcade Side Effects Report #4700821-1
Velcade side effect was reported by a Health Professional from on June 27, 2005. Female patient, 67 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: difficult to wean from ventilator, hypertension, hypoxia, laboratory test abnormal, malignant neoplasm progression, multi-organ failure, multiple myeloma , pleural effusion, renal failure. Velcade dosage: 1.6 MG/M2 INJECTION. During the same period patient was treated with THALIDOMIDE, LEVOTHYROXINE, OXYCONTIN, OXYCODONE, ACYCLOVIR, LEVEFLOXACIN, FLUCONAZOLE, LASIX. Patient died on 04/26/2005.


Velcade Side Effects Report #4976246-0
Velcade side effect was reported by a Physician from AUSTRALIA on Apr 03, 2006. Female patient, 67 years of age, weighting 137.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia , blood pressure decreased, dehydration, malignant neoplasm progression, multiple myeloma , nausea . Velcade dosage: 2.10 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with SPIRONOLACTONE, SOTALOL, FUROSEMIDE, PARACETAMOL, AMIODARONE. Patient died on 05/11/2005.

Velcade Side Effects Report #5020032-2
Velcade side effect was reported by a Physician from CANADA on May 23, 2006. Male patient, 67 years of age, weighting 249.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with MS CONTIN, CELEBREX, METFORMIN, GLYBURIDE, AMITRIPTYLINE, EPREX, RHOVANE, ACETAMINOPHEN. Patient died on 10/12/2004.

Velcade Side Effects Report #6106873-9
Velcade side effect was reported by a Physician from SPAIN on Feb 16, 2009. Male patient, 66 years of age, weighting 209.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bone pain, chest pain , cold sweat, disease progression, multiple myeloma , pneumonia . Velcade dosage: 1.3 MG/M2, INTRAVENOUS; INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4594061-7
Velcade side effect was reported by a Physician from on Feb 10, 2005. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease recurrence, hepatic neoplasm, leukaemia plasmacytic, multiple myeloma . Velcade dosage: 3.50 MG. During the same period patient was treated with STILNOCT, LANSOPRAZOLE, PRIMPERAN, AREDIA, PROPAVAN, DELTISON, BETAPRED. Patient was hospitalized. Patient died on 12/25/2004.

Velcade Side Effects Report #4976251-4
Velcade side effect was reported by a Physician from UNITED KINGDOM on Mar 31, 2006. Male patient, 66 years of age, weighting 163.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium increased, cardiac failure congestive, malignant neoplasm progression, monoclonal immunoglobulin present, multiple myeloma , pulmonary arterial pressure increased. Velcade dosage: unknown. During the same period patient was treated with ALLOPURINOL, GRANISETRON, DEXAMETHASONE, OMEPRAZOLE, PAMIDRONATE DI, RAMIPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 01/21/2006.

Velcade Side Effects Report #5324055-5
Velcade side effect was reported by a Physician from FRANCE on Apr 25, 2007. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.40 MG, INTRAVENOUS. Patient died on 05/23/2006.

Velcade Side Effects Report #5724966-2
Velcade side effect was reported by a Physician from JAPAN on Apr 18, 2008. Female patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 04/07/2008.

Velcade Side Effects Report #5811786-3
Velcade side effect was reported by a Physician from FRANCE on July 10, 2008. Male patient, 65 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease complication, hypercalcaemia, hyperuricaemia, hyperviscosity syndrome, multiple myeloma . Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5874849-2
Velcade side effect was reported by a Physician from JAPAN on Aug 22, 2008. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, multiple myeloma , pleural effusion, renal failure, tumour lysis syndrome. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #4631658-X
Velcade side effect was reported by a Physician from on Mar 25, 2005. Female patient, 65 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac disorder, multiple myeloma , rhabdomyolysis, troponin increased. Velcade dosage: 2.30 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with ALLOPURINOL, UNIPRIL, NEORECORMON, ZOFRAN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4699745-8
Velcade side effect was reported by a Physician from on June 08, 2005. Female patient, 65 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , renal failure, rhabdomyolysis. Velcade dosage: 2.30 MG, 2/WEEKS, IV BOLUS. During the same period patient was treated with ALLOPURINOL, UNIPRIL, NEORECORMON, ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4761377-0
Velcade side effect was reported by a Physician from HUNGARY on Aug 22, 2005. Male patient, 65 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: coagulopathy, dialysis , diarrhoea, hypercalcaemia, leukaemia plasmacytic, multiple myeloma , neoplasm progression, polyuria, renal failure acute. Velcade dosage: 2.30 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4806871-9
Velcade side effect was reported by a Physician from HUNGARY on Oct 04, 2005. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: coagulopathy, dialysis , diarrhoea, disease progression, hypercalcaemia, laboratory test abnormal, leukaemia plasmacytic, multiple myeloma , plasmacytosis. Velcade dosage: 2.30 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 09/28/2005.

Velcade Side Effects Report #4806910-5
Velcade side effect was reported by a Physician from HUNGARY on Oct 04, 2005. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: coagulopathy, dialysis , diarrhoea, hypercalcaemia, leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma , plasmacytosis, polyuria. Velcade dosage: 2.30 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 09/28/2005.

Velcade Side Effects Report #4975860-6
Velcade side effect was reported by a Physician from GERMANY on Mar 31, 2006. Female patient, 65 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, infection , multiple myeloma . Velcade dosage: unknown. Patient was hospitalized. Patient died on 04/16/2005.

Velcade Side Effects Report #4995822-2
Velcade side effect was reported by a Physician from GERMANY on Apr 24, 2006. Female patient, 65 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: infection , malignant neoplasm progression, multiple myeloma , pyrexia. Velcade dosage: 2.40 MG, UNK, INTRAVENOUS. Patient was hospitalized. Patient died on 04/09/2005.

Velcade Side Effects Report #5312928-9
Velcade side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Male patient, 64 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, disease progression, multiple myeloma , speech disorder, tremor. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient died on 04/01/2007.

Velcade Side Effects Report #5387589-3
Velcade side effect was reported by a Physician from DENMARK on June 29, 2007. Female patient, 64 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematemesis, multiple myeloma , terminal state. Velcade dosage: 2.00 MG. During the same period patient was treated with DEXAMETHASONE, NEXIUM. Patient died.

Velcade Side Effects Report #5937664-7
Velcade side effect was reported by a Physician from JAPAN on Oct 17, 2008. Male patient, 64 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, haemoglobin decreased, hypoaesthesia, lymphocyte count decreased, multiple myeloma , pneumonia influenzal, renal impairment. Velcade dosage: 1.6 MG, INTRAVENOUS, 2.1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PARIET, LENDORM, DIFLUCAN, NAIXAN. Patient died on 11/24/2007.

Velcade Side Effects Report #4708809-1
Velcade side effect was reported by a Physician from UNITED KINGDOM on June 20, 2005. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: lower respiratory tract infection, malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.3 MG BIW, IV BOLUS. During the same period patient was treated with ALLOPURINOL, RANITIDINE, GAVISCON, SOLPADOL, PAMIDRONATE DI, ORAMORPH, DICLOFENAC, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 02/19/2003.

Velcade Side Effects Report #5304689-4
Velcade side effect was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Apr 04, 2007. Female patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with NEURONTIN, AMITRIPTYLINE, APPROVEL, GLUCOBAY, NATEGLINIDE. Patient died on 01/16/2007.

Velcade Side Effects Report #5332904-X
Velcade side effect was reported by a Pharmacist from AUSTRALIA on May 09, 2007. Male patient, 63 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , no therapeutic response. Velcade dosage: 2.30 MG,. Patient died on 05/01/2007.

Velcade Side Effects Report #5379572-9
Velcade side effect was reported by a Physician from FRANCE on June 26, 2007. Male patient, 63 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: angina pectoris, disease progression, dyspnoea, haemorrhage, multiple myeloma . Velcade dosage: 1.30 MG. During the same period patient was treated with DEXAMETHASONE. Patient died on 10/15/2006.

Velcade Side Effects Report #5691921-0
Velcade side effect was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, 63 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, disease progression, multiple myeloma , platelet count decreased. Velcade dosage: 2.00 MG UNK INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, VANCOMYCIN, ADONA, MUCOSOLVAN, LANSOPRAZOLE, ITRACONAZOLE, MAGNESIUM OXIDE, OXYCONTIN. Patient died on 01/14/2008.

Velcade Side Effects Report #4815913-6
Velcade side effect was reported by a Physician from POLAND on Oct 13, 2005. Female patient, 63 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemodynamic instability, infection in an immunocompromised host, malignant neoplasm progression, multiple myeloma , urosepsis. Velcade dosage: 1.00 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DURAGESIC, CYCLONAMINE, MILURIT, AREDIA, FUROSEMIDE, RANIGAST. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5030939-8
Velcade side effect was reported by a Physician from UNITED KINGDOM on June 08, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , spinal cord compression. Velcade dosage: unknown. Patient died on 05/24/2006.

Velcade Side Effects Report #5255425-1
Velcade side effect was reported by a Physician from JAPAN on Feb 21, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , pulmonary oedema, renal impairment. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DECADRON. Patient died on 02/02/2007.

Velcade Side Effects Report #5268766-9
Velcade side effect was reported by a Physician from JAPAN on Feb 28, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , pulmonary oedema, renal impairment. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DECADRON. Patient died on 02/02/2007.

Velcade Side Effects Report #5336422-4
Velcade side effect was reported by a Physician from JAPAN on May 10, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, malignant neoplasm progression, multiple myeloma , myelodysplastic syndrome, nausea , pulmonary oedema, respiratory failure, thrombocytopenia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, AMOBAN, CARBAMAZEPINE, LOXONIN, NOVAMIN, OXYCONTIN, PURSENNID. Patient died on 02/02/2007.

Velcade Side Effects Report #5400638-9
Velcade side effect was reported by a Physician from JAPAN on July 11, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, depression , malignant neoplasm progression, multiple myeloma , pneumonia , pulmonary oedema. Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with DEXAMETHASONE, AMOBAN, CARBAMAZEPINE, LOXONIN, NOVAMIN, OXYCONTIN, PURSENNID. Patient died on 02/02/2007.

Velcade Side Effects Report #5587189-6
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2007. Male patient, 62 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, lung disorder, multiple myeloma , oxygen saturation decreased, platelet count decreased, pleural effusion, respiratory disorder. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, WARFARIN, AMOBAN, FAMOTIDINE. Patient recovered.

Velcade Side Effects Report #5615489-X
Velcade side effect was reported by a Physician from IRELAND on Jan 21, 2008. Male patient, 62 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , autonomic neuropathy, constipation , diarrhoea, malignant neoplasm progression, multi-organ failure, multiple myeloma , nervous system disorder, respiratory failure. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOPRAZOLE. Patient was hospitalized. Patient died on 11/28/2007.

Velcade Side Effects Report #5719055-7
Velcade side effect was reported by a Physician from AUSTRALIA on Apr 09, 2008. Male patient, 62 years of age, weighting 205.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma , platelet count decreased. Velcade dosage: 2.80 MG,; 2.20 MG,. During the same period patient was treated with DEXAMETHASONE, METFORMIN, GLYBURIDE. Patient died.

Velcade Side Effects Report #5729656-8
Velcade side effect was reported by a Physician from AUSTRALIA on Apr 21, 2008. Male patient, 62 years of age, weighting 205.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , thrombocytopenia. Velcade dosage: 2.80 MG; 2.20 MG. During the same period patient was treated with DEXAMETHASONE, METFORMIN, GLYBURIDE. Patient died.

Velcade Side Effects Report #5753073-8
Velcade side effect was reported by a Physician from JAPAN on May 14, 2008. Male patient, 62 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, cardiac failure, cardiomegaly, condition aggravated, disease progression, malaise, multiple myeloma , neutropenia. Velcade dosage: 2 MG, INTRAVENOUS, 1.6 MG, INTRAVENOUS, 1.8 MG, INTRAVENOUS, 2.6 MG, INTRAVENOUS. During the same period patient was treated with ORGADRONE. Patient was hospitalized. Patient died on 04/08/2008.

Velcade Side Effects Report #4737828-4
Velcade side effect was reported by a Physician from NETHERLANDS on July 21, 2005. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: emphysema, leukocytoclastic vasculitis, malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, 2/WEEK; IV BOLUS. During the same period patient was treated with PREDNISONE. Patient recovered.